Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vogler

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1996
A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrowW R Vogler, W E Berdel, R B Geller, et al.
Cancer Treatment Reports|April 1, 1986
Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup StudyW R Vogler, H D Preisler, E F Winton, et al.
Cancer Letters|December 1, 1987
Lack of therapeutic activity of the lipoidal amine CP-46,665 in rodent tumors and human non-seminomatous germ cell tumors growing in nude miceW E Berdel, M R Berger, H Falk, et al.
Lipids|December 1, 1991
Comparison of selective cytotoxicity of alkyl lysophospholipidsW R Vogler, A C Olson, S Okamoto, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
Leukemia & Lymphoma|May 1, 1993
Long-term outcome of patients with acute myelogenous leukemia: the role of maintenance therapy, consolidation therapy and the predictive value of two in vitro assaysA Raza, H D Preisler, G P Browman, et al.
British Journal of Haematology|August 1, 1994
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapyL T Goodnough, T H Price, C A Parvin, et al.
Transfusion|May 1, 1986
A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donorsR G Strauss, J P Hester, W R Vogler, et al.
Cancer Treatment Reports|July 1, 1985
Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study GroupE F Winton, E B Hearn, O Martelo, et al.
American Journal of Hematology|November 1, 1983
The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemiaG Browman, J Goldberg, A J Gottlieb, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Advances in Experimental Medicine and Biology|January 1, 1996
A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrowW R Vogler, W E Berdel, R B Geller, et al.
Cancer Treatment Reports|April 1, 1986
Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup StudyW R Vogler, H D Preisler, E F Winton, et al.
Cancer Letters|December 1, 1987
Lack of therapeutic activity of the lipoidal amine CP-46,665 in rodent tumors and human non-seminomatous germ cell tumors growing in nude miceW E Berdel, M R Berger, H Falk, et al.
Lipids|December 1, 1991
Comparison of selective cytotoxicity of alkyl lysophospholipidsW R Vogler, A C Olson, S Okamoto, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
Leukemia & Lymphoma|May 1, 1993
Long-term outcome of patients with acute myelogenous leukemia: the role of maintenance therapy, consolidation therapy and the predictive value of two in vitro assaysA Raza, H D Preisler, G P Browman, et al.
British Journal of Haematology|August 1, 1994
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapyL T Goodnough, T H Price, C A Parvin, et al.
Transfusion|May 1, 1986
A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donorsR G Strauss, J P Hester, W R Vogler, et al.
Cancer Treatment Reports|July 1, 1985
Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study GroupE F Winton, E B Hearn, O Martelo, et al.
American Journal of Hematology|November 1, 1983
The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemiaG Browman, J Goldberg, A J Gottlieb, et al.
Pageof 19